Smad-mediated Transcription Is Required for Transforming Growth Factor-β1-induced p57Kip2 Proteolysis in Osteoblastic Cells*
暂无分享,去创建一个
K. Miyazono | Keiji Tanaka | T. Imamura | T. Chiba | H. Toyoshima | Y. Tanaka | T. Fujita | M. Fujii | T. Igarashi | S. Nishimori | H. Kawaguchi | Tohru Ogasawara | Yoshikazu Tanaka
[1] W. Krek,et al. The F‐box protein Skp2 is a ubiquitylation target of a Cul1‐based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts , 2000, The EMBO journal.
[2] Alexander Varshavsky,et al. The ubiquitin system. , 1998, Annual review of biochemistry.
[3] A. Koff,et al. Cell-cycle inhibitors: three families united by a common cause. , 2000, Gene.
[4] J. Massagué,et al. Controlling TGF-β signaling , 2000, Genes & Development.
[5] J. Wrana. Regulation of Smad Activity , 2000, Cell.
[6] K. Miyazono,et al. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. , 1999, Molecular biology of the cell.
[7] K. Nasmyth,et al. Whose end is destruction: cell division and the anaphase-promoting complex. , 1999, Genes & development.
[8] M. Peter,et al. Ubiquitin-dependent degradation of multiple F-box proteins by an autocatalytic mechanism. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[9] Michele Pagano,et al. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 , 1999, Nature Cell Biology.
[10] James M. Roberts,et al. CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.
[11] S. Elledge,et al. Skipping into the E2F1-destruction pathway , 1999, Nature Cell Biology.
[12] Y. Ouchi,et al. p57Kip2 Is Degraded through the Proteasome in Osteoblasts Stimulated to Proliferation by Transforming Growth Factor β1* , 1999, The Journal of Biological Chemistry.
[13] Xing Shen,et al. Smads bind directly to the Jun family of AP-1 transcription factors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[14] T. Maniatis,et al. A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways. , 1999, Genes & development.
[15] P. Howe,et al. TGF‐β induces fibronectin synthesis through a c‐Jun N‐terminal kinase‐dependent, Smad4‐independent pathway , 1999, The EMBO journal.
[16] R. Deshaies. SCF and Cullin/Ring H2-based ubiquitin ligases. , 1999, Annual review of cell and developmental biology.
[17] R. Derynck,et al. Transcriptional Activators of TGF-β Responses: Smads , 1998, Cell.
[18] P. Howley,et al. Ubiquitination and degradation of the substrate recognition subunits of SCF ubiquitin-protein ligases. , 1998, Molecular cell.
[19] L. Zhan,et al. The role of p38 MAP kinase in TGF-beta1-induced signal transduction in human neutrophils. , 1998, Biochemical and biophysical research communications.
[20] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[21] Kohei Miyazono,et al. TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.
[22] A. Yamaguchi,et al. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. , 1997, The Journal of clinical investigation.
[23] S. Elledge,et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndrome , 1997, Nature.
[24] M. Barbacid,et al. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. , 1997, Genes & development.
[25] R. Davis,et al. Evidence for a Role of Rho-like GTPases and Stress-activated Protein Kinase/c-Jun N-terminal Kinase (SAPK/JNK) in Transforming Growth Factor β-mediated Signaling* , 1997, The Journal of Biological Chemistry.
[26] J. Massagué,et al. GS domain mutations that constitutively activate T beta R‐I, the downstream signaling component in the TGF‐beta receptor complex. , 1995, The EMBO journal.
[27] K. M. Mulder,et al. Transforming Growth Factor β Activation of p44mapk in Proliferating Cultures of Epithelial Cells (*) , 1995, The Journal of Biological Chemistry.
[28] K. Miyazono,et al. Characterization of type I receptors for transforming growth factor-beta and activin. , 1994, Science.
[29] K. Miyazono,et al. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor , 1993, Cell.
[30] M. Sporn,et al. Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro , 1987, The Journal of cell biology.
[31] G. Church,et al. Genomic sequencing. , 1993, Methods in molecular biology.
[32] D. V. Cohn,et al. Target cells in bone for parathormone and calcitonin are different: enrichment for each cell type by sequential digestion of mouse calvaria and selective adhesion to polymeric surfaces. , 1975, Proceedings of the National Academy of Sciences of the United States of America.